This HubSpot Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
Analysts downgraded HubSpot, Group 1 Automotive, Align Technology, AutoNation and more, cutting ratings and price targets.
Stocks · News reference
Oversold health care stocks Align Technology, Dianthus Therapeutics and Ocular Therapeutix show RSI readings near or below 30, signaling potential value.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Analysts downgraded HubSpot, Group 1 Automotive, Align Technology, AutoNation and more, cutting ratings and price targets.
Analysts raised targets for ON, AMD and WTFC, while cutting GNRC, LAD, ALGN, PLNT and CRDO; ALGN was downgraded.
U.S. stock futures fell as HubSpot dropped after a downgrade; Roze AI, UMC, Quantum-Si, Intel and others also declined premarket.
Dianthus Therapeutics granted equity awards to six newly-hired, non-executive employees on October 1, 2026. The inducement grants consist of non-qualified stock options to purchase 106,000 shares of common stock with an exercise price of $88.32 per share and a 10-year term, vesting 25% after one year followed by equal monthly installments over 36 months.
Wall Street analysts initiated coverage on PPG, Shopify, Chesapeake Utilities, Global Payments and Dianthus, with targets ranging from $101 to $160.